These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12353965)

  • 21. TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists.
    Williams VL; Cohen PR
    Int J Dermatol; 2011 May; 50(5):619-25. PubMed ID: 21506984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of patients with infliximab-induced lupus erythematosus and outcomes after retreatment with a second anti-TNF agent.
    Subramanian S; Yajnik V; Sands BE; Cullen G; Korzenik JR
    Inflamm Bowel Dis; 2011 Jan; 17(1):99-104. PubMed ID: 20629183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adalimumab-induced lupus erythematosus with central nervous system involvement in a patient with Crohn's disease.
    Vannucchi V; Grazzini M; Pieralli F; Giannotta M; Biagioni C; Nozzoli C
    J Gastrointestin Liver Dis; 2011 Jun; 20(2):201-3. PubMed ID: 21725519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug-induced systemic lupus erythematosus in ankylosing spondylitis associated with infliximab.
    Pérez-García C; Maymo J; Lisbona Pérez MP; Almirall Bernabé M; Carbonell Abelló J
    Rheumatology (Oxford); 2006 Jan; 45(1):114-6. PubMed ID: 16319096
    [No Abstract]   [Full Text] [Related]  

  • 25. Inflammatory bowel disease and lupus: a systematic review of the literature.
    Katsanos KH; Voulgari PV; Tsianos EV
    J Crohns Colitis; 2012 Aug; 6(7):735-42. PubMed ID: 22504032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-TNF-alpha-induced systemic lupus syndrome.
    Debandt M; Vittecoq O; Descamps V; Le Loët X; Meyer O
    Clin Rheumatol; 2003 Feb; 22(1):56-61. PubMed ID: 12605321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of inflammatory diseases: safety of long-term use of infliximab].
    Schaible TF
    Presse Med; 2001 Mar; 30(12):610-3. PubMed ID: 11317923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infliximab-induced lupus-like reaction in a patient with psoriatic arthritis.
    Pallotta P; Cianchini G; Ruffelli M; Puddu P
    Rheumatology (Oxford); 2006 Jan; 45(1):116-7. PubMed ID: 16319094
    [No Abstract]   [Full Text] [Related]  

  • 29. Drug-induced lupus due to anti-tumor necrosis factor alpha agents.
    Costa MF; Said NR; Zimmermann B
    Semin Arthritis Rheum; 2008 Jun; 37(6):381-7. PubMed ID: 17977585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retrobulbar optic neuritis associated with infliximab in a patient with Crohn disease.
    Strong BY; Erny BC; Herzenberg H; Razzeca KJ
    Ann Intern Med; 2004 Apr; 140(8):W34. PubMed ID: 15096366
    [No Abstract]   [Full Text] [Related]  

  • 31. Development of systemic lupus erythematosus in a patient with rheumatoid arthritis following treatment conversion of infliximab to adalimumab.
    Havel J; Aboutalebi S; Doughty L; Wirges M
    J Drugs Dermatol; 2008 Aug; 7(8):796-8. PubMed ID: 18720701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mucosal healing of Crohn's disease in a patient with concurrent systemic lupus erythematosus using infliximab.
    Kagaya Y; Sakamoto H; Yano T; Sunada K; Lefor AK; Niki T; Yamamoto H
    Clin J Gastroenterol; 2017 Jun; 10(3):244-249. PubMed ID: 28364315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug-induced lupus erythematosus presenting with cardiac tamponade: a case report and literature review.
    Harnett DT; Chandra-Sekhar HB; Hamilton SF
    Can J Cardiol; 2014 Feb; 30(2):247.e11-2. PubMed ID: 24373757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug-induced lupus and autoimmune hepatitis secondary to infliximab for psoriasis.
    Dang LJ; Lubel JS; Gunatheesan S; Hosking P; Su J
    Australas J Dermatol; 2014 Feb; 55(1):75-9. PubMed ID: 23651182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-nuclear antibody positivity and the use of certolizumab in inflammatory bowel disease patients who have had arthralgias or lupus-like reactions from infliximab or adalimumab.
    Verma HD; Scherl EJ; Jacob VE; Bosworth BP
    J Dig Dis; 2011 Oct; 12(5):379-83. PubMed ID: 21955431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is the risk of tumour necrosis factor inhibitor-induced lupus or lupus-like syndrome the same with monoclonal antibodies and soluble receptor? A case/non-case study in a nationwide pharmacovigilance database.
    Moulis G; Sommet A; Lapeyre-Mestre M; Montastruc JL;
    Rheumatology (Oxford); 2014 Oct; 53(10):1864-71. PubMed ID: 24899660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Infliximab-related lupus and associated valvulitis: a case report and review of the literature.
    Chadha T; Hernandez JE
    Arthritis Rheum; 2006 Feb; 55(1):163-6. PubMed ID: 16463396
    [No Abstract]   [Full Text] [Related]  

  • 38. Systematic review of infliximab-induced autoantibodies and systemic lupus erythematosus.
    Vaz JL; Andrade CA; Pereira AC; Martins Mde F; Levy RA
    Rev Bras Reumatol; 2013 Aug; 53(4):358-64. PubMed ID: 24217668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Guttate psoriasis induced by infliximab in a child with Crohn's disease.
    Costa-Romero M; Coto-Segura P; Suarez-Saavedra S; Ramos-Polo E; Santos-Juanes J
    Inflamm Bowel Dis; 2008 Oct; 14(10):1462-3. PubMed ID: 18383177
    [No Abstract]   [Full Text] [Related]  

  • 40. Managing immunogenic responses to infliximab: treatment implications for patients with Crohn's disease.
    Han PD; Cohen RD
    Drugs; 2004; 64(16):1767-77. PubMed ID: 15301561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.